Literature DB >> 22777500

Recognizing unusual manifestations of Hodgkin lymphoma.

Nicholas A Barber1, Philip J Bierman.   

Abstract

Hodgkin lymphoma (HL) is a rare malignancy of the lymphatic system that is curable in at least 80 % of patients. Although patients usually present with painless lymphadenopathy, a variety of systemic and organ-specific syndromes may also exist in relation to HL. These syndromes may develop before, during, or after the diagnosis of HL and may also indicate disease relapse. Most of these unusual disorders resolve with successful HL treatment but some may require adjunctive supportive therapies before a response is achieved. Oncologists should be familiar with these syndromes because early recognition may result in a more timely diagnosis of HL which may lead to improved outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777500     DOI: 10.1007/s11899-012-0131-4

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  41 in total

1.  Paraneoplastic glomerulopathies: new insights into an old entity.

Authors:  P M Ronco
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

2.  Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.

Authors:  P Sillevis Smitt; A Kinoshita; B De Leeuw; W Moll; M Coesmans; D Jaarsma; S Henzen-Logmans; C Vecht; C De Zeeuw; N Sekiyama; S Nakanishi; R Shigemoto
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

3.  Skin as the primary site of Hodgkin's disease: a case report of primary cutaneous Hodgkin's disease and review of its relationship with non-Hodgkin's lymphoma.

Authors:  J Guitart; D Fretzin
Journal:  Am J Dermatopathol       Date:  1998-04       Impact factor: 1.533

4.  Abnormal coagulation results in patients with Hodgkin's disease.

Authors:  E J Seifter; R I Parker; H R Gralnick; M Wesley; V T DeVita; R C Young; D L Longo
Journal:  Am J Med       Date:  1985-06       Impact factor: 4.965

Review 5.  The role of cytokines in classical Hodgkin lymphoma.

Authors:  Brian F Skinnider; Tak W Mak
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

6.  Indolent course of the cutaneous Hodgkin's disease.

Authors:  Vladimir Jurisić; Marina Bogunović; Natasa Colovic; Milica Colović
Journal:  J Cutan Pathol       Date:  2005-02       Impact factor: 1.587

7.  Hypoglycaemia due to an insulin-receptor antibody in Hodgkin's disease.

Authors:  E G Walters; J M Tavaré; R M Denton; G Walters
Journal:  Lancet       Date:  1987-01-31       Impact factor: 79.321

8.  Erythema nodosum heralding recurrent Hodgkin's disease.

Authors:  S Simon; S J Azevedo; J J Byrnes
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

9.  Microcytosis in Hodgkin disease associated with unbalanced globin chain synthesis.

Authors:  J L Fahey; S Rahbar; M J Farbstein; S J Forman; K G Blume; E Beutler
Journal:  Am J Hematol       Date:  1986-10       Impact factor: 10.047

10.  Hodgkin's disease presenting with isolated craniospinal involvement.

Authors:  B L Bender; D G Mayernik
Journal:  Cancer       Date:  1986-10-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.